CANF · AMEX
Can-Fite BioPharma (CANF) Stock Price & Fundamentals
Can-Fite BioPharma (CANF) closed at $938.00 on Oct 9, 2026, up 0.79% from the previous close of $930.65.
Share price, past year
1Y +22.36%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $938.00 |
| Sep 30, 2026 | $905.83 |
| Aug 31, 2026 | $862.78 |
| Jul 31, 2026 | $848.61 |
| Jun 30, 2026 | $795.22 |
| May 29, 2026 | $842.20 |
| Apr 30, 2026 | $792.19 |
| Mar 31, 2026 | $782.82 |
| Feb 27, 2026 | $816.70 |
| Jan 30, 2026 | $808.37 |
| Dec 31, 2025 | $789.02 |
| Nov 28, 2025 | $776.60 |
| Oct 31, 2025 | $775.97 |
Key statistics
- Market cap
- $2.46B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 2.6M
- Dividend yield
- —
- 52-week range
- $746.27 – $938.00
Can-Fite BioPharma's market cap is $2.46B, based on a share price of $938.00 and 2.6M shares outstanding as of Dec 31, 2025.
Financials
Can-Fite BioPharma reported revenue of $405.00K for fiscal 2025, down 39.91% from fiscal 2024.
Can-Fite BioPharma reported a net loss of $9.83M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $405.00K | −39.9% | −$9.83M | −2,426.7% | −$5.97 | −$8.95M |
| FY2024ended Dec 31, 2024 | $674.00K | −9.3% | −$7.88M | −1,169.1% | −$10.86 | −$7.64M |
| FY2023ended Dec 31, 2023 | $743.00K | −8.3% | −$7.63M | −1,027.5% | −$17.92 | −$8.44M |
| FY2022ended Dec 31, 2022 | $810.00K | −5.0% | −$10.17M | −1,255.9% | −$0.01 | −$10.81M |
| FY2021ended Dec 31, 2021 | $853.00K | +11.8% | −$12.62M | −1,478.9% | −$0.03 | −$9.87M |
| FY2020ended Dec 31, 2020 | $763.00K | −62.5% | −$14.44M | −1,892.9% | −$0.04 | −$12.09M |
| FY2019ended Dec 31, 2019 | $2.03M | −46.8% | −$12.63M | −621.3% | — | −$11.09M |
| FY2018ended Dec 31, 2018 | $3.82M | — | −$6.57M | −172.0% | — | −$4.19M |
Company profile
- Name
- Can-Fite BioPharma Ltd.
- Ticker
- CANF
- Exchange
- AMEX
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 26 Ben Gurion Street, Ramat Gan, L3 5257346
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001536196
Frequently asked questions
What is Can-Fite BioPharma's stock price?
Can-Fite BioPharma (CANF) closed at $938.00 on Oct 9, 2026, up 0.79% from the previous close of $930.65.
What is Can-Fite BioPharma's market cap?
Can-Fite BioPharma's market cap is $2.46B, based on a share price of $938.00 and 2.6M shares outstanding as of Dec 31, 2025.
How much revenue does Can-Fite BioPharma make?
Can-Fite BioPharma reported revenue of $405.00K for fiscal 2025, down 39.91% from fiscal 2024.
Sources and methodology
Fundamentals come from Can-Fite BioPharma Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures